Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 4.26% | $11.87M | $275.09B | 34.29% | 75 Outperform | |
| ORANGE SA | 3.87% | $10.77M | €37.80B | 46.78% | 65 Neutral | |
| NN Group N.V. | 3.34% | $9.30M | €15.96B | 37.82% | 68 Neutral | |
| BNP Paribas | 3.31% | $9.21M | €76.48B | 17.24% | 64 Neutral | |
| E.ON SE | 3.19% | $8.88M | €40.40B | 30.75% | 60 Neutral | |
| Sony | 3.19% | $8.87M | ¥28.63T | 61.80% | 74 Outperform | |
| Hitachi,Ltd. | 3.12% | $8.68M | ¥23.93T | 38.87% | 77 Outperform | |
| Mitsubishi UFJ Financial Group | 3.10% | $8.62M | ¥27.15T | 29.70% | 75 Outperform | |
| TotalEnergies SE | 2.96% | $8.23M | €119.29B | -0.54% | 79 Outperform | |
| Roche Holding AG | 2.90% | $8.08M | CHF232.45B | 22.76% | 73 Outperform |